Jeff Jones
Corporate Officer/Principal chez ARATANA THERAPEUTICS INC
Profil
Jeff Jones is currently a Managing Director & Senior Analyst at Oppenheimer & Co., Inc. He is also a Vice President-Business Development at Aratana Therapeutics, Inc. Prior to these roles, he worked at Durham Jones & Pinegar PC.
Dr. Jones has also worked as a Principal at Emerging Technology Partners LLC and as the Chief Operating Officer & Vice President at PharmAthene, Inc. He has an undergraduate degree from the University of Virginia, a doctorate from Baylor College of Medicine, and an MBA from Johnson Graduate School of Management.
Postes actifs de Jeff Jones
| Sociétés | Poste | Début |
|---|---|---|
| ARATANA THERAPEUTICS INC | Corporate Officer/Principal | - |
Oppenheimer & Co., Inc. (Broker)
 Oppenheimer & Co., Inc. (Broker) Investment Banks/BrokersFinance Oppenheimer & Co., Inc. (Broker) (Oppenheimer-Broker) is the global full-service brokerage division of Oppenheimer & Co., Inc., an investment boutique headquartered in New York City with additional offices nationwide. Founded in 1975, the firm is owned directly by Viner Finance Inc., an indirect subsidiary of Oppenheimer Holdings Inc. (NYSE: OPY). Oppenheimer-Broker offers a full array of brokerage services to retail, institutional, and corporate clients. | Analyst-Equity | 01/01/2021 |
Anciens postes connus de Jeff Jones
| Sociétés | Poste | Fin |
|---|---|---|
PharmAthene, Inc.
 PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | Directeur des opérations | 17/09/2015 |
Emerging Technology Partners LLC
 Emerging Technology Partners LLC Investment ManagersFinance Emerging Technology Partners LLC (ETP) is a venture capital firm founded in 2000 by Wei-Wu He and Bill Snider. The firm is headquartered in San Francisco, California. | Corporate Officer/Principal | - |
Formation de Jeff Jones
| Baylor College of Medicine | Doctorate Degree |
| Johnson Graduate School of Management | Masters Business Admin |
| University of Virginia | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
PharmAthene, Inc.
PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | Health Technology |
Aratana Therapeutics, Inc.
 Aratana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aratana Therapeutics, Inc. engages in the development and commercialization of pet therapeutics. Its portfolio includes NOCITA, ENTYCE, and GALLIPRANT. NOCITA (bupivacaine liposome injectable suspension) acts as a local post-operative analgesia for cranial cruciate ligament surgery in dogs, and as a peripheral nerve block to provide regional post-operative analgesia following onychectomy in cats. ENTYCE(capromorelin oral solution) is intended for appetite stimulation in dogs. GALLIPRANT (grapiprant tablets) is for the control of pain and inflammation associated with osteoarthritis in dogs. The company was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Leawood, KS. | Health Technology |
Emerging Technology Partners LLC
Emerging Technology Partners LLC Investment ManagersFinance Emerging Technology Partners LLC (ETP) is a venture capital firm founded in 2000 by Wei-Wu He and Bill Snider. The firm is headquartered in San Francisco, California. | Finance |
Oppenheimer & Co., Inc. (Broker)
Oppenheimer & Co., Inc. (Broker) Investment Banks/BrokersFinance Oppenheimer & Co., Inc. (Broker) (Oppenheimer-Broker) is the global full-service brokerage division of Oppenheimer & Co., Inc., an investment boutique headquartered in New York City with additional offices nationwide. Founded in 1975, the firm is owned directly by Viner Finance Inc., an indirect subsidiary of Oppenheimer Holdings Inc. (NYSE: OPY). Oppenheimer-Broker offers a full array of brokerage services to retail, institutional, and corporate clients. | Finance |